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Abstract  
OBJECTIVE: A significant number of breast cancer patients, during their life with the diagnosis, 
experience emotional distress in the form of depression and anxiety. Psychological resilience is the 
ability of a person to protect his/her mental health when faced with adverse circumstances such as 
the cancer diagnosis. This study aims to assess the resilience in breast cancer patients and to ex-
plore whether depression affects the resilience.  
MATERIAL AND METHODS: Two hundred eighteen (218) women, treated for early breast cancer 
responded to Connor - Davidson Resilience Scale and Hospital Depression and Anxiety Scale, in 
order to assess the level of psychological resilience and the level of depression.  
RESULTS: There is a significant negative correlation between depression and resilience in our 
sample (r = - 0.562, p < 0.001). Individuals with higher levels of depression have lower levels of 
psychological resilience. There is no statistically significant correlation between the ages of the 
participants; time passed since diagnosis, cancer stage and resilience levels.  
CONCLUSION: This study shows that patients who are less depressed have higher levels of resil-
ience and that psychological resilience may independently contribute to lower levels of depression 
among breast cancer patients. The level of psychological resilience may be a protective factor for 
depression and psychological distress. 
 
 
 
 
 
 
 
Introduction 
 
Psychosocial and behavioral studies of can-
cer survivors show a wide variety of effects of the dis-
ease and treatments upon the lives of patients and 
their families. These studies come to the conclusion 
that being a "disease-free" does not mean to be "free 
from the disease." Cancer has power to influence all 
aspects of the human health: physical, functional, 
psychological/cognitive, social, economic and spiritu-
al. Through conversation and following the life stories 
of people being treated for cancer, researchers have 
noted that although the experience is often cata-
strophic, many patients show high level of resilience 
when faced with disease. 
Cancer patients suffer from much different 
psychiatric comorbidity, but the most frequently diag-
nosed are depressive disorder, anxiety disorders 
(panic disorder, post-traumatic stress disorder, and 
phobias), adjustment disorders and delirium [1]. Often, 
patients have mixed condition or a combination of 
symptoms such as depression and anxiety. 
In the literature, one can find many different 
data on the prevalence of clinically significant depres-
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sion in oncology patients. These differences depend 
on the location and stage of cancer, the demographic 
characteristics of examined population, diagnostic 
criteria and instruments used, method of assessment, 
and many other factors [2]. Generally, it is estimated 
that 10% to 25% of cancer patients have clinically sig-
nificant depressive symptoms [3, 4], with higher 
prevalence in late life of patients [5], and in malignant 
diseases with worse prognosis, such as pancreatic 
cancer and oropharyngeal cancer [6, 7]. It is believed 
that the incidence of depression in patients with can-
cer is 3 to 4 times more common than in the general 
population [8]. Potential reasons for the inconsistency 
in the literature include differences in methodology 
(many different tools for screening and diagnosis of 
depression are used), there are too much differences 
in defining the research population, and often the en-
tire population of patients with breast cancer is com-
prised without taking into consideration the singularity 
of time period passed since the diagnosis [9]. 
Depression in patients with malignant disease 
contributes to reduced quality of life [10], a higher rate 
of suicide and desire for hastened death [11], poorer 
adherence to the oncology treatment [12], greater 
physical suffering [13] and prolonged hospital stays 
[14]. There is evidence that depression is an inde-
pendent risk factor for mortality in patients with malig-
nant diseases [15-18]. 
Cancer as a diagnosis is associated with psy-
chological distress across all points of the trajectory of 
the disease. Many factors contribute to this psycho-
logical suffering such as the feeling of uncertainty 
about the future, loss of the autonomy and the sense 
of control over the changes in life and the possibility of 
disability, fear of suffering and death and existential 
worries [19].  
Patients with breast cancer show a higher 
rate of five-year survival compared to other malignan-
cies in women. It is believed that the survival rate of 
patients with breast cancer is between 80% and 95% 
[20]. The diagnosis of breast cancer is no longer con-
sidered as a fatal diagnosis, and is more and more 
accepted as a disease with positive treatment out-
comes. Although the disease is successfully treated, 
the actual diagnosis of cancer and treatment that pa-
tients must undergo are very stressful. Clinicians 
should be aware of the frequency of depression in 
cancer patients and early identify the psychological 
symptoms. Early detection and treatment of depres-
sion in patients with breast cancer improves the pa-
tients’ quality of life and increases the probability of 
successful recovery [21]. The period after completion 
of the initial oncologic treatment is also a time of tran-
sition when women need to transform their role of 
"breast cancer patient" to the role of "symptom-free 
patient" or "survivor" [22]. The depressive disorder is 
often underestimated in patients with breast cancer 
[23, 24]. It is considered that depressive disorder is 
most common in the period when the diagnosis of 
breast cancer is established. The depressive disorder 
later in life after the initial therapy for breast cancer is 
not thoroughly researched. During regular oncological 
follow-up examinations, psychological needs of pa-
tients living with no signs of cancer are often over-
looked [25]. One of the prominent causes for devel-
opment of depression among breast cancer survivors 
is the fear of cancer recurrence or occurrence of me-
tastases [26]. 
Very important psycho-social factor regarding 
the psychological suffering of cancer patients is their 
resilience. Resilience implies the ability of a person to 
protect or recover his/her mental health despite the 
existence of objective difficulties. Resilience is not a 
single feature of the person but it is a result of the in-
teractions between multiple personality traits and envi-
ronmental factors [27].  It is believed that higher levels 
of resilience protect a person from psychiatric disor-
ders. In cancer patients, higher levels of resilience are 
associated with better quality of life and lower levels of 
depression in patients [28]. Given that most resilience 
studies in cancer patients are cross-sectional studies, 
it is difficult to derive a reliable conclusion whether 
people who are resilient suffer less from psychological 
distress or the lesser psychological suffering makes 
people more resilient when dealing with an adversity. 
The ability of patients to protect their mental health 
and experience positive psychological growth when 
faced with catastrophic experience is insufficiently 
explored.  
This study aims to assess the resilience in 
breast cancer patients and to explore whether de-
pression affects the resilience of patients suffering 
from breast cancer. 
 
 
Material and Methodology 
 
The study was conducted in the oncology de-
partment of the Clinical Hospital "Dr. Trifun Panovski " 
in Bitola and University Clinic for Oncology and Radio-
therapy in Skopje. Participation in the study was of-
fered to all patients who came for a follow-up in the 
oncology wards in Bitola and Skopje and who met the 
inclusion criteria. Data for 218 patients have been 
compiled and analyzed in this study, women treated 
for breast cancer, older than 18 years, treated with 
different oncological therapies and that are in a differ-
ent time period from the initial treatment of malignant 
disease. 
 
Inclusion criteria 
The diagnosis of early breast cancer to be 
based on histopathology analysis (stage I, II and III); 
Patients with breast cancer can be included in the 
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study if they have completed the initial surgical and 
oncological treatment at least 1 month prior the inter-
view; Patients who have or have had metastasis can-
not be included in the study; Patients who have 
comorbid or pre-existing brain disorders in the form of 
delirium, encephalopathy or other disorder in the 
course of treatment were not included in the study; 
Patients included in the study had no history of psy-
chiatric illnesses (schizophrenia spectrum, schizotypal 
and delusional disorders, affective disorders, diag-
nosed personality disorders, addiction) before the di-
agnosis of breast cancer. 
 
 
Figure 1: Depression according to HADS scale, cut-off HADS-D ≥ 8 
 
 
Participants answered the following question-
naires: 
1. Questionnaire for psychosocial and on-
cologic parameters specifically designed for the study. 
2. Connor-Davidson Resilience Scale 25 (CD-
RISC25) [29, 30],  is a self-evaluation instrument of 25 
items that are ranked on a Likert scale from 0 to 4 
points. The full range of the scale is from 0-100 points, 
where higher scores indicate higher resilience. 
3. Hospital Anxiety Depression Scale (HADS) 
[31-33], - for self-assessment of anxiety and depres-
sion. The HADS scale contains 14 items: 7 for as-
sessment of anxiety symptoms and 7 for assessment 
of depressive symptoms. For each item there are four 
possible answers scored from 0 to 3 points. The total 
sum of both subscales (depression, anxiety) is inter-
preted as follows: 0-7 no symptoms, 8-10 borderline 
case, 11 points and more than 11 indicates clinically 
significant anxiety or depression. In studies with can-
cer patients, researchers accepted to use cut-off ≥ 8 
points on HADS-D subscale for clinically significant 
depression. 
All participants have given a written informed 
consent for participation in the study. The study was 
approved by The Ethics Committee for research on 
people at the Medical Faculty in Skopje. 
 
 
Results 
 
The mean resilience score of the whole group 
is 74.7 (0-100) SD 17.0, and the mean depression 
score on HADS-D is 5 (SD 4.2).  The not depressed 
subgroup had mean resilience of 79.1 (SD 14.6), the 
subthreshold group had 68.2 (SD 14.3) and the major 
depression group had mean levels of resilience of 
56.4 (SD 18.7). 
Table 1: Summary of demographic and oncological data  
Demographic Information Cancer Diagnosis and Treatment 
Age / Range 30-90 Stage 186 
Age / Mean (years) 60.2  I 52 (27.9%) 
Marital Status 216 II 74 (39.8%) 
Married 147 (68%)  III 60 (32.3%) 
Never Married 13 (6%) Time from diagnosis 211 
Other (Divorced, widowed) 56 (25.9%) 6 months-1 year 23 (10.9%) 
People in household 217 1-2 years 28 (13.2%) 
Only the patient 27 (12.4%) 2-5 years 74 (35.1%) 
Shares with other/s family 
members 
190 (87.6%) >5 years 86 (40.8%) 
Patient is parent 218 Type of Treatment 218 
Yes 198 (90.8%) ChemoTh+RadioTh+Surgery 104 (47.7%) 
No 20 (9.2%) ChemoTh+Surgery 72 (33%) 
Age of Patients' Children 192 RadioTh+Surgery 11 (5%) 
<10 years old 6 Surgery 31 (14.2%) 
11-20 17 (8.9%) Type of Surgery 212 
21-30 55 (28.6%) Partial Mastectomy 40 (18.9%) 
>31 114 (59.4%) Mastectomy 165 (77.8%) 
Education 217 Double Mastectomy 7 (3.3%) 
Primary School 56 (25.8%) Adjuvant Therapy (present) 206 
Secondary School 88 (40.6%) Yes 134 (65%) 
University  73 (33.6%) No 72 (35%) 
Employment 214 Type of Medication 121 
Employed 58 (27.1%) Tamoxifen 108 (89.2%) 
Unemployed 50 (23.4%) Aromatase Inhibitor 13 (10.8%) 
Retired 106 (49.5%) Who financially supports 
the family? 
214 
Place of residence 200 Patient alone 58 (27.1%) 
Urban area 167 (83.5%) Patient's partner 36 (16.4%) 
Rural area 33 (16.5%) Patient and partner together 86 (40.2%) 
Family Net Monthly Income 214 Other 34 (15.9%) 
Up to 10000 MKD (160 EUR) 58 (27.1%) No of individuals in the 
social support network 
195 
10000-30000 MKD (160-500 
EUR) 
116 (54.2%) 0 individuals 5 (2.6%) 
>30000 MKD (>500 EUR) 40 (18.7%) 1-5 individuals 73 (37.4%) 
  >5 individuals 117 (60%) 
 
 
There is strong negative correlation between 
the level of resilience and the level of depression on 
the HADS-D subscale (r = - 0.562, p < 0.001). The 
level of resilience does not correlate with the age of 
participants (r = - 0.077; p = 0.263). 
Table 2: Comparison of means of resilience in 3 groups of pa-
tients (not depressed, subthreshold depression, major depres-
sion) 
Not depressed vs. Subthreshold Depression t = 3.863, df =186 P < 0.001 
Not depressed vs. Major Depression t = 6.026, df =182 P < 0.001 
Subthreshold Depression vs. Major Depression t = 2.681, df =56 P = 0.01 
 
 
Discussion 
 
The aim of the study was to explore whether 
higher levels of resilience are associated with the level 
of depression in breast cancer patients. The findings 
confirm the hypothesis that the level of resilience is 
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negatively correlated with the level of depression in 
women treated for breast cancer. Higher levels of re-
silience may represent a protective factor from the 
emotional suffering of people who are dealing with 
significant stressful life event such as a cancer diag-
nosis. In our sample, the association between depres-
sion and resilience is statistically significant, although 
one can not reliably tell the direction of the connection 
between these two variables. On one hand it is possi-
ble that the low level of emotional distress causes 
higher levels of resilience, on the other hand the high 
level of resilience leads to less emotional suffering. 
Further longitudinal research is needed to examine 
whether high levels of resilience represent a long-term 
protection from depression/emotional suffering and to 
examine the relation of these two variables [34].  The-
se findings should be evaluated with caution due to 
the relatively small sample and the cross-sectional 
design of the study; however they are a good basis for 
further research in this area. 
In our sample, 12.4% of the patients suffered 
from major depression, and additional 14.7% suffered 
from depressive symptoms that altogether did not 
reach the criteria for major depression (subthreshold 
group). The levels of resilience are higher in not de-
pressed group, than the subthreshold and major de-
pression group. Also subthreshold depression group 
has better levels of resilience than major depression 
group. Our results show that even mild severity of de-
pression reflects in the levels of resilience. 
In our sample there was no statistical signifi-
cance between the depression and time passed since 
diagnosis, and the stage of cancer p > 0.05. This find-
ing is contrary to the literature data in which the level 
of depression decreases over time after the initial 
shock of the diagnosis and the treatment. More exten-
sive research is required to reach a valid conclusion 
that will refer to our population. 
If we collect more data from our population, 
about what helps oncology patients to be resilient, all 
healthcare professionals can create specific psycho-
social interventions that target resilience. These inter-
ventions for enhancing psychological resilience may 
be a useful approach in overcoming the psychological 
distress in people who are dealing with breast cancer 
[35], to improve adherence to oncology treatments, 
and to improve the overall quality of life of the patients 
and their families. 
In conclusion, this study shows that psycho-
logical resilience may independently contribute to 
lower levels of depression and psychological distress 
among patients treated for breast cancer. Patients 
who are less depressed have higher levels of resili-
ence. More extensive research is required to verify the 
impact of higher levels of psychological distress on 
resilience and to establish the direction of the impact 
of these two phenomena. The level of psychological 
resilience may be a protective factor for depression 
and psychological distress. 
Various psychosocial interventions to en-
hance psychological resilience may be useful ap-
proach in overcoming the psychological distress in 
people who are dealing with breast cancer. Based on 
data from our population, we can identify specific ob-
jectives for which psychosocial interventions can be 
implemented in clinical practice. 
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